KIAA1671 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.086000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.897800E-01
Normal-vs-Stage2
8.791600E-01
Normal-vs-Stage3
3.974200E-01
Normal-vs-Stage4
9.725800E-01
Stage1-vs-Stage2
1.041990E-01
Stage1-vs-Stage3
6.359600E-02
Stage1-vs-Stage4
4.172600E-01
Stage2-vs-Stage3
1.703850E-01
Stage2-vs-Stage4
8.115000E-01
Stage3-vs-Stage4
2.602600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.841000E-01
Normal-vs-AfricanAmerican
7.434400E-01
Normal-vs-Asian
8.611000E-01
Caucasian-vs-AfricanAmerican
3.992800E-01
Caucasian-vs-Asian
9.036200E-01
AfricanAmerican-vs-Asian
4.560400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.475400E-01
Normal-vs-Female
9.705000E-01
Male-vs-Female
5.548400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.482000E-01
Normal-vs-Age(41-60Yrs)
8.289800E-01
Normal-vs-Age(61-80Yrs)
7.974000E-01
Normal-vs-Age(81-100Yrs)
4.998800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.251200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.976400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.089800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
8.905700E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.194500E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.643800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.789600E-01
Normal-vs-Daily Drinker
4.361400E-01
Normal-vs-Weekly Drinker
6.227800E-01
Normal-vs-Occasional Drinker
9.970800E-01
Normal-vs-Social Drinker
9.659200E-01
Non Drinker-vs-Daily Drinker
1.902640E-01
Non Drinker-vs-Weekly Drinker
4.518800E-01
Non Drinker-vs-Occasional Drinker
7.395400E-01
Non Drinker-vs-Social Drinker
6.942200E-01
Daily Drinker-vs-Weekly Drinker
7.434200E-01
Daily Drinker-vs-Occasional Drinker
1.025970E-01
Daily Drinker-vs-Social Drinker
1.167630E-01
Weekly Drinker-vs-Occasional Drinker
2.995600E-01
Weekly Drinker-vs-Social Drinker
3.114000E-01
Occasional Drinker-vs-Social Drinker
9.242000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.966400E-02
Normal-vs-Grade 2
4.963800E-03
Normal-vs-Grade 3
6.264500E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.691400E-01
Grade 1-vs-Grade 3
9.970600E-01
Grade 1-vs-Grade 4
4.966400E-02
Grade 2-vs-Grade 3
9.479600E-01
Grade 2-vs-Grade 4
4.963800E-03
Grade 3-vs-Grade 4
6.264500E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.876000E-01
Normal-vs-NonDiabetic
8.976200E-01
Diabetic-vs-NonDiabetic
1.646630E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.221400E-01
Normal-vs-NoPancreatitis
8.101000E-01
Pancreatitis-vs-NoPancreatitis
7.830600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.777000E-01
Normal-vs-N1
9.134000E-01
N0-vs-N1
8.394800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.154600E-01
Normal-vs-TP53-NonMutant
5.780800E-01
TP53-Mutant-vs-TP53-NonMutant
5.357200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
